In patients with type 2 diabetes or insulin resistance, the ability of insulin to stimulate skeletal muscle glucose transport is altered [78,79] due to an impaired GLUT4 translocation to the muscle cell surface [80]. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.